Healthy volunteers
Conditions
Interventions
None listed
Sponsors
Oryzon Genomics S.A.
Eligibility
Sex/Gender
Male
Age
18 Years to 64 Years
Outcome results
None listed
A PHASE 1, OPEN-LABEL STUDY TO ASSESS THE ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION, INCLUDING THE MASS BALANCE, OF A SINGLE ORAL DOSE OF [14C]-VAFIDEMSTAT IN HEALTHY MALE PARTICIPANTS
For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms
Source: EU CTIS · Data processed: May 1, 2026